The aim is to explore the potential of Digital Transformation and Pharma 4.0™ projects within the Life Science Industry. Enabling technologies alone are not the answer to challenges that our industry has to face, but they are a key element of a wider solution, inclusive of revised business and compliance processes, innovative and sustainable digital solutions and equipment and, as a key enabler, new organization and culture.
New opportunities offered by recent and emerging technologies are completely changing the game and making new scenarios possible, even the ones considered impossible a few years ago. Our goal is to deep dive transformational, but industry proven, ways of extracting benefits from Digital Solutions that combine one or more innovative enabling technologies, like: GxP Cloud, Smart and Wearable Devices, Collaboration Platforms, Big Data and Advanced Analytics, Industrial Internet of Things (IIoT), Artificial Intelligence / Machine Learning (AI/ML), Process Mining, Natural Language Processing, Image Recognition, Advanced Modeling, Advanced Robotics, Augmented Reality (AR), Virtual Reality (VR), Additive Manufacturing, Robotic Process Automation (RPA), but also the ones less mature in our industry like: Biometric identification, Blockchain, Speech and Gesture Recognition, Edge Computing and Quantum Computing.
Each case study to be eligible should clearly share the problem statement, the solution, the benefits (whenever possible quantitative - the dimension of the project, involved Users, timelines), the constraints, and lesson learned. Best will be to have, at least as co-speaker, a representative of the case study owner company.